Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PP 1 (CAS 172889-26-8)

5.0(1)
Write a reviewAsk a question

See product citations (6)

Alternate Names:
1-tert-butyl-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine; 4-Amino-5-(methylphenyl)-7-(tert.butyl)pyrazolo-(3,4-d)pyrimidine
Application:
PP 1 is a selective and potent Src family tyrosine kinase inhibitor
CAS Number:
172889-26-8
Purity:
≥98%
Molecular Weight:
281.36
Molecular Formula:
C16H19N5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PP 1 is a selective and potent Src family tyrosine kinase inhibitor. PP 1 studies have proved its ability to potently inhibit Lck and Fyn (FynT), IL-2 gene activation in T lymphocytes, and anti-CD3-induced protein tyrosine phosphorylation. Research indicates that PP 1 effectively blocks LPA and EGF-enhanced tyrosine phosphorylation, MAPK activation downstream of EGFR, Rsk-1 (p90RSK) activation by H2O2, Kit and Bcr-Abl tyrosine kinases, and degrades RETMEN2A and RETMEN2B oncoproteins via proteosomal targeting. Rat basophilic leukemia cell studies have shown that PP 1 inhibits Fc epsilonRI- and Thy-1-mediated activation. Structural studies have revealed that PP 1 binds to the ATP-binding site in tyrosine kinases and Ser/Thr kinases.


PP 1 (CAS 172889-26-8) References

  1. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.  |  Osterhout, DJ., et al. 1999. J Cell Biol. 145: 1209-18. PMID: 10366594
  2. Structural basis for selective inhibition of Src family kinases by PP1.  |  Liu, Y., et al. 1999. Chem Biol. 6: 671-8. PMID: 10467133
  3. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras.  |  Abe, J., et al. 2000. J Biol Chem. 275: 1739-48. PMID: 10636870
  4. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.  |  Tatton, L., et al. 2003. J Biol Chem. 278: 4847-53. PMID: 12475982
  5. The specificities of protein kinase inhibitors: an update.  |  Bain, J., et al. 2003. Biochem J. 371: 199-204. PMID: 12534346
  6. PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.  |  Carniti, C., et al. 2003. Cancer Res. 63: 2234-43. PMID: 12727845
  7. Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling.  |  Wittköpper, K., et al. 2011. Cardiovasc Res. 91: 392-401. PMID: 21354993
  8. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.  |  Hanke, JH., et al. 1996. J Biol Chem. 271: 695-701. PMID: 8557675
  9. Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins.  |  Kwon, YG., et al. 1997. Proc Natl Acad Sci U S A. 94: 3536-41. PMID: 9108011
  10. Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells.  |  Amoui, M., et al. 1997. Eur J Immunol. 27: 1881-6. PMID: 9295022
  11. Signal characteristics of G protein-transactivated EGF receptor.  |  Daub, H., et al. 1997. EMBO J. 16: 7032-44. PMID: 9384582
  12. Tyrosine kinases of the Src family participate in signaling to MAP kinase from both Gq and Gi-coupled receptors.  |  Igishi, T. and Gutkind, JS. 1998. Biochem Biophys Res Commun. 244: 5-10. PMID: 9514877
  13. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.  |  Tang, H., et al. 1998. J Biol Chem. 273: 18268-72. PMID: 9660790

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PP 1, 1 mg

sc-203212
1 mg
$86.00

PP 1, 5 mg

sc-203212A
5 mg
$145.00